Inventor · disambiguated record
Dominique Bourel
Also filed as: BOUREL DOMINIQUE
21 granted patents·8 pending applications·224 citations·filing 1997–2017
95Inventor score
Files withLAB FRANCAIS DU FRACTIONNEMENT15BELIARD ROLAND5LFB BIOTECHNOLOGIES4AETSRN1BOUREL DOMINIQUE1
Top patents by PatentIndex Score
29 records- 0196US7931895B2Monoclonal antibodies with enhanced ADCC functionLFB BIOTECHNOLOGIES·Filed 2005·Granted Apr 26, 2011·36 cites·22 claims
- 0295US8685725B2Monoclonal antibodies with enhanced ADCC functionBELIARD ROLAND·Filed 2011·Granted Apr 1, 2014·24 cites·26 claims
- 0394US8409572B2Monoclonal antibodies with enhanced ADCC functionBELIARD ROLAND·Filed 2012·Granted Apr 2, 2013·17 cites·19 claims
- 0494US7579170B2Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIIILAB FRANCAIS DU FRACTIONNEMENT·Filed 2001·Granted Aug 25, 2009·44 cites·9 claims
- 0590US7713524B2Use of ADCC-optimized antibodies for treating low-responder patientsLFB BIOTECHNOLOGIES·Filed 2004·Granted May 11, 2010·34 cites·10 claims
- 0684US7541029B2Anti-rhesus D monoclonal antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2006·Granted Jun 2, 2009·4 cites·4 claims
- 0783US8501171B2Use of ADCC-optimized antibodies for treating weak patientsBOUREL DOMINIQUE·Filed 2010·Granted Aug 6, 2013·9 cites·10 claims
- 0883US8153124B2Method for treating cancer using monoclonal antibodiesBELIARD ROLAND·Filed 2009·Granted Apr 10, 2012·3 cites·22 claims
- 0978US6932969B1Ig fractions having immunomodulatory activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2000·Granted Aug 23, 2005·22 cites·13 claims
- 1077US9708409B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Jul 18, 2017·1 cites·16 claims
- 1176US9718890B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Aug 1, 2017·1 cites·20 claims
- 1275US9718889B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Aug 1, 2017·1 cites·27 claims
- 1371US8124078B2Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodiesBELIARD ROLAND·Filed 2009·Granted Feb 28, 2012·0 cites·25 claims
- 1470US8178093B2Method for treating infectious disease using monoclonal antibodiesBELIARD ROLAND·Filed 2009·Granted May 15, 2012·0 cites·22 claims
- 1570US5851524AHuman monoclonal anti-rhesus (D) antibodies and cell lines producing sameAETSRN·Filed 1997·Granted Dec 22, 1998·25 cites·5 claims
- 1669US10081683B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Granted Sep 25, 2018·0 cites·14 claims
- 1764US8357370B2Anti-D monoclonal antibodiesLFB BIOTECHNOLOGIES·Filed 2012·Granted Jan 22, 2013·0 cites·16 claims
- 1861US9109020B2Use of ADCC-optimized antibodies for treating weak patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Aug 18, 2015·0 cites·10 claims
- 1960US2010145026A1Antibody for ADCC And Inducing Cytokine ProductionLFB BIOTECHNOLOGIES·Filed 2009·Application pending·0 cites
- 2059US7790399B2Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptorsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2004·Granted Sep 7, 2010·1 cites·13 claims
- 2158US2006127392A1Antibody for adcc and inducing cytokine productionFRACTIONNEMENT ET DES BIOETCHN·Filed 2003·Application pending·0 cites
- 2258US2010323368A1Cytokine production-inducing antibodyLAB FRANCAIS DU FRACTIONNEMENT·Filed 2009·Application pending·0 cites
- 2357US2009081216A1Treatment of pathologies which escape the immune response, using optimized antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2008·Application pending·0 cites
- 2456US7595165B2Method of measuring activation of effector cellsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2003·Granted Sep 29, 2009·2 cites·1 claims
- 2554US9879089B2Use of ADCC-optimized antibodies for treating low-responder patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jan 30, 2018·0 cites·14 claims
- 2653US2007218052A1Novel lgG3 Antibodies for Stimulating PhagocytosisLABOPRATOIRE FRANCAIS DU FRACT·Filed 2004·Application pending·0 cites
- 2750US2005271652A1Treatment of pathologies which escape the immune response, using optimised antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2003·Application pending·0 cites
- 2847US2007015239A1Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2004·Application pending·0 cites
- 2935US2005089520A1Antibody stimulating il-ira productionFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dominique Bourel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →